Journal
NEUROREPORT
Volume 13, Issue 7, Pages 931-933Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200205240-00006
Keywords
anterior hypothalamus; flank marking; medial preoptic; scent marking; social behavior
Categories
Funding
- NIMH NIH HHS [MH 62641] Funding Source: Medline
- NINDS NIH HHS [NS 37232] Funding Source: Medline
Ask authors/readers for more resources
The present study investigated whether serotonin (5-HT) agonists could inhibit the ability of arginine-vasopressin (AVP) to induce a form of scent marking called flank marking by their actions in the medial preoptic-anterior hypothalamus (MPOA-AH). DOI, a 5-HT2A,2B,2C receptor agonist, did not inhibit AVP-induced flank marking, but mCPP a 5-HT2A antagonist and 5-HT2B,2C agonist inhibited AVP-induced flank marking. In addition, the finding that 8-OH-DPAT, CGS-12066A and SC53116 also inhibited AVP-induced flank marking suggests that 5-HT could also inhibit flank marking by acting through 5-HT1A, 5-HT7,5-HTIB and/or 5-HT4 receptor subtypes. These data support the hypothesis that 5-HT acts within the MPOA-AH to inhibit the ability of AVP to induce flank marking. NeuroReport 13:931-933 (C) 2002 Lippincott Williams Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available